# Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

> **NCT02970019** · PHASE1 · COMPLETED · sponsor: **Sun Pharma Advanced Research Company Limited** · enrollment: 60 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** K0706
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02970019
- **Lead sponsor:** Sun Pharma Advanced Research Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-30
- **Primary completion:** 2019-05-28
- **Final completion:** 2019-05-28
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-03-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02970019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02970019, "Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02970019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*